LifeSpan Vision Ventures
Norwalk, Connecticut, United StatesFounded 2022
LifeSpan Vision Ventures is a venture capital firm that invests in companies developing diagnostics and therapeutics focused on longevity and aging reversal. Based in Norwalk, Connecticut, the firm finances game-changing longevity technologies aimed at extending healthy human lifespan past 120 years.
44% of their portfolio is in Biotech & Life Sciences. Their most common stage is seed (44% of deals). Average disclosed round size is $12.9M (across 4 rounds with reported amounts).
Portfolio
9
Fund Size
—
Top Stage
Seed
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
9 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 EpiBone | Unknown | — | Nov 2024 |
| IIntegrated Biosciences | Seed | $17.2M | Oct 2024 |
| LLIfT Biosciences | Series A | — | Sep 2024 |
 Remedium Bio | Unknown | — | Sep 2024 |
| MMatter Bio | Seed | $7M | May 2024 |
 Senisca | Seed | — | Mar 2024 |
 Akadeum | Series B | $17.5M | Oct 2021 |
 TECregen | Seed | — | — |
| RRemedium | Series A | $10M | — |
Top Co-Investors
Beringea1 shared
Berkeley Catalyst Fund1 shared
Agilent Technologies1 shared
University of Michigan1 shared
Arbor Ventures1 shared
Michigan Capital Network1 shared
Bluestone Equity Partners1 shared
Kendall Capital Partners1 shared
Carma Fund1 shared
High-Tech Gründerfonds1 shared
APEX Ventures1 shared
Eli Lilly and Company1 shared
Starbloom Capital1 shared
Last updated: 8 September 2026